Mesothelioma Cancer Studies Currently Recruiting Participants at the University of Chicago Comprehensive Cancer Center

Study Number Title
10-138-A Dynamic Perfusion Computed Tomography for Malignant Pleural Mesothelioma
Select
10-290-A CALGB 30901: Randomized Phase II Study of Maintenance Pemetrexed Versus Observation for Patients with Malignant Pleural Mesothelioma without Progression after First-Line Chemotherapy
11-0755 The International Association for the Study of Lung Cancer IASLC Prospective Malignant Pleural Mesothelioma Staging Project
Select
12-0032 Phase II Srudy of Erlotinib for Patients with Malignant Peritoneal Mesothelioma (MPeM) Exhibiting EGFR Mutations
Select
12-2200 A Phase IB Study to Evaluate the Safety and Induction of Immune Response of CRS-207 in Combination with Pemetrexed and Cisplatin as Front-line Therapy in Adults with Malignant Pleural Mesothelioma
Select
IRB13-0359 A Phase 2b Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second or Third-line Treatment of Subjects with Unresectable Pleural or Peritoneal Malignant Mesothelioma
Select
IRB13-0751 A Phase II Randomized, Double-Blind, Placebo-Controlled,Multicenter Study of VS-6063 in Subjects with Malignant Pleural Mesothelioma
9571 Tissue Procurement for Lung Cancer, Esophageal Cancer, Thymoma, and Mesothelioma in Patients Undergoing Surgery or Biopsy
11132A Computerized Analysis of Mesothelioma on Thoracic Computed Tomography Scans
13473A Utilization of Previously Banked Tissue from Patients with Lung Cancer, Mesothelioma, Thymoma/Thymic Carcinoma, and Esophageal Cancer and Correlation with Clinical Data.

To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.